Hyderabad, Sep 26 (UNI) Dr Reddy’s Laboratories Limited along with its subsidiaries together on Saturday announced the launch of Dimethyl Fumarate Delayed-Release Capsules, a therapeutic equivalent generic version of Tecfidera (dimethyl fumarate) Delayed-Release Capsules, approved by the US Food and Drug Administration (USFDA).

The Tecfidera brand and generic market had US sales of approximately USD 3.8 billion MAT for the most recent 12 months ending June 2020, according to IQVIA Health.

Dr Reddy’s Dimethyl Fumarate Delayed-Release Capsules was available in 120 mg and 240 mg in bottle count sizes of 14 and 60 capsules, respectively, a company release here said.

UNI VV CS 1645